A grade PMID 42321916
View analysis →Finding therapies hidden in 39,000 pediatric cancer papers.
Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
Ranked Discovery Journal Articles
A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →Database feed
All ranked pediatric cancer papers
In a retrospective single-center cohort of patients undergoing central neurocytoma resection, the transcortical approach and third ventricular invasion were associated with persistent or later hydrocephalus outcomes despite similar immediate postoperative hydrocephalus rates between surgical approaches.
The reported evidence supports TC approach and third ventricular invasion as prognostic associations; it is reasonable—but unproven—to hypothesize that approach selection when anatomically feasible and risk-adapted postoperative surveillance could reduce or enable earlier management of hydrocephalus-related morbidity.
In a retrospective cohort of 333 patients undergoing curative-intent hepatectomy for hepatocellular carcinoma, higher preoperative ALBI grade was associated with more postoperative liver-related complications and independently predicted 6-month mortality and poorer overall survival.
The evidence supports ALBI as an accessible prognostic and perioperative risk-stratification marker in this surgical cohort; it is reasonable but unproven to infer that incorporating ALBI into resection planning could improve patient selection or reduce postoperative harm, and no pediatric-specific benefit is established.
This scoping review identified 24 guidelines and related recommendations for surveillance and long-term follow-up of pediatric, adolescent, and young adult CNS tumor survivors, summarized them across survivorship domains, and highlighted discordance and evidence gaps.
The supplied evidence shows that existing survivorship recommendations can be organized to identify areas of agreement, inconsistency, and unmet need; it is reasonable but unproven to infer that more coordinated, evidence-based surveillance could enable earlier management of late effects and improve survivor outcomes.
This cross-sectional school-based survey in six ethnic autonomous prefectures of Qinghai found that guardians’ willingness to vaccinate girls against HPV was associated with ethnicity, attitudes, subjective norms, perceived behavioral control, cues to action, and perceived barriers.
The study provides associative evidence that culturally tailored school and primary-care recommendations, clear vaccine information, and logistical support may improve guardians’ willingness; whether these strategies causally increase HPV vaccine uptake and ultimately reduce HPV-related cervical cancer requires prospective implementation studies.
In a questionnaire and cancer-registry analysis of 4,847 patients aged 18–39 years, desire for future children and interest in fertility consultation varied by age, sex, parental status, cancer type, and treatment characteristics.
The study provides observational evidence that identifiable AYA subgroups differ in fertility goals and consultation interest; it supports the inference that systematic pre-treatment fertility counseling and referral could reduce unmet fertility needs, but it does not test whether such an intervention preserves fertility or improves quality of life.
This review describes vaginal stimuli-responsive in-situ gels as a potential localized drug-delivery strategy for cervical cancer, emphasizing retention, sustained release, reduced systemic exposure, and possible compatibility with fertility-preserving treatment.
The review proposes—but the supplied record does not clinically demonstrate—that temperature-, pH-, or light-responsive vaginal gels could improve local drug retention and delivery, potentially reducing systemic toxicity and enabling preoperative tumor reduction in younger patients.
In a single-center retrospective cohort of 431 pediatric adnexal lesions, O-RADS and IOTA-SR had comparable overall diagnostic performance, but IOTA-SR achieved a higher AUC for lesions ≥10 cm.
The evidence supports pediatric risk stratification rather than a therapy: IOTA-SR may classify large adnexal lesions more accurately than O-RADS; it is an inference requiring prospective validation that adopting this approach could improve surgical triage, reduce unnecessary intervention, or expedite oncologic management.
This five-year retrospective study of 169 HSCT patients with CLABSI at a Jordanian cancer center reports predominance of Gram-negative infections, frequent multidrug resistance, substantial Hickman-device representation, and 30-, 60-, and 100-day post-infection survival rates of 83.4%, 80.5%, and 78.1%, respectively.
The study provides descriptive evidence that Gram-negative and multidrug-resistant pathogens are common among CLABSIs in this center; it is reasonable—but not tested here—to hypothesize that locally tailored antimicrobial stewardship, empiric-treatment protocols, surveillance, and central-line prevention measures could improve outcomes.
This illustrative case reports diagnostic sampling of a deep cerebellar lesion in an 11-year-old boy through a suboccipital transhorizontal fissure corridor, followed by intact neurological function at 6 months.
Evidence from this single case shows that the horizontal fissure provided operative access with minimal reported parenchymal disruption and no observed neurological deficit; it may therefore offer a function-preserving alternative for selected deep pediatric cerebellar lesions, but comparative safety, resection efficacy, and generalizability remain unproven.
In a matched cross-sectional Danish cohort, 298 ALL survivors treated with the NOPHO ALL2008 protocol had the largest adjusted bone mineral density deficits at hip sites after high-risk therapy, with no evidence of the partial normalization seen in standard- and intermediate-risk groups.
The evidence supports risk-adapted long-term skeletal monitoring, particularly after high-risk ALL therapy; it can be inferred—but was not tested—that earlier surveillance or targeted bone-health interventions might reduce later skeletal morbidity.
This human observational study reports chemotherapy-associated sperm DNA-methylation network modules correlated with sperm parameters, reproductive hormones, and specific agents such as cisplatin in adult male survivors of adolescent osteosarcoma.
The evidence supports associations between prior chemotherapy and later sperm epigenetic, endocrine, and reproductive features; it suggests—but does not establish—that these signatures could eventually help identify gonadotoxic exposures or guide fertility-preservation and survivorship strategies.
This systematic review identified 32 studies covering 27 psychosocial interventions for siblings of children with chronic medical conditions—mostly pediatric cancer—but found substantial heterogeneity, only two randomized trials, and generally low study quality.
The evidence shows that sibling-focused psychosocial interventions have been implemented and evaluated, but does not establish efficacy; it is reasonable to hypothesize that rigorously designed, standardized interventions could improve sibling psychosocial outcomes and family supportive care in pediatric oncology.